Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
For randomised clinical trials, the Jadad scale ( To complement the Jadad score, the Cochrane Risk of Bias Tool (RoB 2) (Sterne et al., 2019) was also used for RCTs to provide a domain-based qualitative evaluation, assessing risks related to selection, performance, detection, attrition, and reporting
Clearer thinking
User 3 split AM and PM doses evenly
Whether treating a chronic condition or optimizing health, most patients can benefit from MIC-B12 therapy
US$ 29.18
US$ 28.19
US$ 25.40
US$ 29.30
US$ 26.68
US$ 20.57
